1. Home
  2. RGEN vs JBTM Comparison

RGEN vs JBTM Comparison

Compare RGEN & JBTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$186.79

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Logo JBT Marel Corporation

JBTM

JBT Marel Corporation

N/A

Current Price

$113.71

Market Cap

6.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
JBTM
Founded
1981
1994
Country
United States
United States
Employees
2000
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
6.9B
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
RGEN
JBTM
Price
$186.79
$113.71
Analyst Decision
Buy
Strong Buy
Analyst Count
12
2
Target Price
$167.67
$180.00
AVG Volume (30 Days)
840.6K
451.3K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
0.34%
EPS Growth
286.96
N/A
EPS
0.24
1.40
Revenue
$141,236,000.00
$3,798,200,000.00
Revenue This Year
$14.30
$8.10
Revenue Next Year
$14.52
$4.68
P/E Ratio
$778.13
$80.96
Revenue Growth
35.10
121.34
52 Week Low
$100.99
$109.63
52 Week High
$188.73
$170.19

Technical Indicators

Market Signals
Indicator
RGEN
JBTM
Relative Strength Index (RSI) 67.84 42.85
Support Level $158.15 N/A
Resistance Level $188.73 $120.86
Average True Range (ATR) 5.75 2.75
MACD 1.05 0.44
Stochastic Oscillator 96.88 38.55

Price Performance

Historical Comparison
RGEN
JBTM

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About JBTM JBT Marel Corporation

JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.

Share on Social Networks: